Hospitalization costs |
Hospitalization costs |
Hospitalization costs |
Hospitalization costs |
Hospitalization costs |
Mean cost per patient at 18 months
|
2 448 ± 8254
[2234; 2661]
|
2100 ± 3476
[2061 ; 2138]
|
2 275 ± 5 278
[2217; 2332]
|
4 157 ± 3 535
[4106; 4208]
|
Difference of cost as compared to 2G strategy
|
-
|
-352 ± 115
[-359 ; -345]
|
-177 ± 115
[-185 ; -170]
|
1705 ± 115
[1697 ; 1712]
|
Failure |
Failure |
Failure |
Failure |
Failure |
Rate of patients without failure at 18 months
|
90.1%
[89.3-90.8]
|
87.3%
[86.9-87.6]
|
79.4%
[79.0-79.9]
|
97.2%
[97.0 ; 97.5]
|
Difference in the proportion of patients without failure at 18 months,
as compared to 2G
|
-
|
-2.8%
[-2.8 ; -2.8]
|
-10.6%
[-10.7 ; -10.6]
|
+7.1%
[7.1 ; 7.2]
|
Complication |
Complication |
Complication |
Complication |
Complication |
Proportion of patients without complication at
18
months
|
97.9%
[97.5-98.3]
|
98.3%
[98.1-98.4]
|
98.4%
[98.3-98.6]
|
94.2%
[93.9 ; 94.6]
|
Difference in the proportion of patients without complication at 18
months, as compared to 2G
|
-
|
+0.4%
[0.4 ; 0.4]
|
+0.5%
[0.5 ; 0.5]
|
-3.7%
[-3.7 ; -3.7]
|